10:22am Wednesday 19 February 2020

Research reveals early potential for new cholesterol drug


The results suggest it may significantly increase levels of good cholesterol and lower levels of bad cholesterol.

Too much harmful cholesterol in your blood can increase your risk of getting cardiovascular disease. The risk is particularly high if you have a high level of LDL cholesterol (bad cholesterol) and a low level of HDL cholesterol (good cholesterol).

The trial involved 398 patients with elevated levels of bad cholesterol and low levels of good cholesterol.


We need to see studies on a larger scale to determine how beneficial this drug will be

Our senior cardiac nurse, Natasha Stewart, said: “This study indicates that evacetrapib may potentially have some effect on helping to lower bad cholesterol and improve good cholesterol levels in the blood. However, it is a very small study performed over a very short period of time, and we need to see studies on a larger scale to determine how beneficial this drug will be in the long run.

“We already know statins can be beneficial in reducing the level of cholesterol in your blood, and help to protect healthy but high-risk people from heart disease, as well preventing repeated problems in people who have already had a heart attack, a stroke or been diagnosed with peripheral artery disease.

“We also know that making simple changes in your lifestyle such as having a diet that is low in fat, and participating in regular physical activity, can also help lower your cholesterol and keep your heart healthy.”

The research was presented at the American Heart Association’s Scientific Sessions 2011.

British Heart Foundation is a registered Charity No. 225971. Registered as a Company limited by guarantee in England & Wales No. 699547.
Registered office at Greater London House, 180 Hampstead Road, London NW1 7AW. Registered as a Charity in Scotland No. SC039426

Share on:

MORE FROM Blood, Heart and Circulation

Health news